Full member
Uvez Sokak, No:5ArnavutköyBesiktas34345 IstanbulTurkey
www.212.vc >
GP - Independent (no parent)Venture Capital
SeedStart-upOther early stageExpansionGrowth capital
Business and Industrial ServicesCommunicationsComputer and Consumer ElectronicsConsumer Services: othersEnergy and EnvironmentFinancial ServicesLife Sciences
AlbaniaAustriaAzerbaijanBelarusBelgiumCyprusDenmarkEuropeFinlandFranceGermanyGreeceIcelandIrelandItalyLiechtensteinLuxembourgMaltaNetherlandsNorwayPolandPortugalSpainSwedenSwitzerlandUnited KingdomWestern Europe
Mr. Ali Karabey, Managing PartnerMs. Ezabel Nihmet, CFOMr. Numan Numan, Managing DirectorMr. Sercan Zulfikar
212 Capital Partners I
€ 27,000,000
2012
Early stage fund,Balanced fund (early stage and development),Growth fund,Generalist fund (all stages)
212 Regional Fund II
€ 30,000,000
2019
Early stage fund,Growth fund,Generalist fund (all stages)
212 is the leading VC fund in Turkey with focus on Europe, Turkey and MENA since 2012
Opern TurmBockenheimer Landstraße 2-460306 Frankfurt am MainGermany
T: +49 69 710 00 00www.3i.com >
GP - Independent (no parent)
Mid market buyout (€15m-€150m equity)Large buyout (€150m-€300m equity)Infrastructure
Business and Industrial ProductsBusiness and Industrial ServicesConsumer Goods and RetailConsumer Services: othersInfrastructure Healthcare Business and Technology Services
EuropeUnited States of AmericaWestern Europe
Mr. Philipp Bruchmann, DirectorMr. Piotr Doniec, Senior AssociateMr. Stephan Duwe, AssociateMr. Andreas Gold, DirectorMs. Rupert Howard, DirectorMr. Charlie Kickham, AssociateMr. Severin Matten, Associate DirectorMr. Christoph Rinnert, Associate DirectorMr. Michael Specht, DirectorMr. Nicolas Urban, Associate DirectorDr. Ulf von Haacke, Partner and Managing DirectorMr. Martin Vonberg, AssociateMs. Kristina Wiren, AssociateMr. Peter Wirtz, Partner and Managing Director
3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core markets are northern Europe and North America.
Cornelis Schuytstraat 721071 JL AmsterdamNetherlands
T: +31 20 305 74 44www.3i.com >
Mr. Menno Antal, Managing Partner, Co-Head Private EquityMr. Mark Bakker, DirectorMr. Pieter de Jong, Managing DirectorMr. Allard Jacobs, Senior AssociateMr. Boris Kawohl, PartnerMs. Jelle Klein Tesselink , AssociateMr. Justin Pabst, AssociateMr. Bastiaan Peer, DirectorMr. Sander Ruijter , DirectorMr. Karel van der Voorden , Senior AssociateMr. Robert Van Goethem, Partner, Head of Consumer SectorMs. Flore Van Schaik , AssociateMr. Rutger Vos, Associate Director
29 rue de Berri75008 ParisFrance
T: +33 1 73 15 11 00www.3i.com >
Mr. Guillaume Basquin, DirectorMr. Chouaib Benlahoussine , AssociateMr. Remi Carnimolla, Partner & Managing DirectorMr. Frédéric Chiche, DirectorMr. Adrien Delmotte, Senior AssociateMr. Stéphane Duhr, DirectorMr. Stéphane Grandguillaume, PartnerMs. Juliette Grognet, AssociateMr. Jacques Henry-Grislain , Senior AssociateMr. Jonas Marciano, AnalystMs. Celine Maronne, DirectorMr. Antoine Matton, DirectorMr. Jeremy Nakache, Associate DirectorMr. Marc Ohayon, Senior Associate
16 Palace StreetLondon SW1E 5JDUnited Kingdom
T: +44 20 79 75 31 31www.3i.com >
Mr. George Archer, Banking DirectorMr. Matt Barker, PartnerMr. Simon Borrows, Chief ExecutiveMr. John Cavill, PartnerMr. Aaron Church, PartnerMr. James Cox, Portfolio Director, Asset Management GroupMr. Jonathan Crane, PartnerMs. Anna Dellis, PartnerMr. Kevin Dunn, General Counsel, Company Secretary & Head of HRMs. Jennifer Dunstan, Partner, Fund Investor RelationsMr. Matt Edwards, Associate DirectorMs. Rowena Gracey, DirectorMs. Imogen Harvey, PR Manager Mr. Manoj Jain, Director, Group Finance OperationsMr. Sachin Jivanji, Associate DirectorMs. Laura Kaps, Senior AssociateMr. Anil Kohli, Banking PartnerMr. Rick Lethbridge, AssociateMr. Tony Lissaman, COO, Private EquityMr. Ian Lobley, PartnerMs. Joy McCormack, Associate Director, Business Leaders NetworkMr. Nigel Middleton, PartnerMr. Neel Mistry, Senior AssociateMr. Thomas Monteiro, Senior AssociateMr. Scott Moseley, PartnerMs. Rebecca PhilbrowMr. Sebastian Schwengber, Associate DirectorMr. Paras Shah, AssociateMr. Tim Short, PartnerMr. Bernardo Sottomayor, PartnerMr. David Stephens, DirectorMr. Jamie Supple, Senior AssociateMs. Joanna Thomson, Active Partnership Practice DirectorMr. Oscar Tylegard, DirectorMs. Kathryn van der Kroft, Communications DirectorMr. Yaad Virdee, Associate DirectorMs. Sophia Walwyn-James, Associate DirectorMr. Phil White, PartnerMr. Pete Wilson, Partner
ul. Sienna 72/600-833 WarsawPoland
T: +48 22/890.22.15F: +48 22/890.22.15www.3tscapital.com >
ExpansionGrowth capital
CommunicationsComputer and Consumer ElectronicsConsumer Goods and RetailConsumer Services: othersICT and Technology Enabled Services
EuropeUnited States of America
Mr. Zbigniew Lapinski, Senior PartnerMs. Katarzyna Pac-Malesa, Investment Manager
3TS Capital Partners is one of the leading European technology focused private equity and venture capital firms. 3TS provides expansion capital and buyout funding for small and medium-sized businesses in growth sectors including Technology & Internet, Media & Communications and Technology-Enabled Services.
50-52 Putul lui Zamfir St.2nd Floor, Ap 5011367 BucharestRomania
T: +40 31/100.02.59F: +40 31/100.02.60www.3tscapital.com >
Ms. Alina Georgescu, Investment ManagerMr. Marius Ghenea, Managing Partner Catalyst RomaniaMr. Alin Stanciu, Partner Catalyst Romania
Itämerenkatu 11-13 00180 HelsinkiFinland
www.3tscapital.com >
Mr. Pekka Santeri Mäki, Managing Partner
Bauernmarkt 241010 ViennaAustria
T: +43 1 890 16 98www.3tscapital.com >
Mr. Andreas Huber, Chief Operating OfficerMs. Katarina Hudakova, Financial ManagerMs. Ivelina Koleva, Office Management, Marketing AssistantMr. Pekka Mäki, Managing PartnerMr. Piotr Sliwa, Investment Manager
78 Pall MallLondon SW1Y 5ESUnited Kingdom
T: +44 (0)203 865 5365www.4biocapital.com >
SeedStart-upFormation through to Series AExpansionGrowth capital
Life Sciences
AustriaBelgiumCanadaDenmarkEuropeFinlandFranceGermanyIcelandIrelandIsraelItalyJapanLuxembourgNetherlandsNorwaySingaporeSpainSwedenSwitzerlandUnited KingdomUnited States of AmericaWestern Europe
Dr. Vasily Fedorin, Operations DirectorMr. Andrey Kozlov, Managing PartnerDr. Dmitry Kuzmin, Managing PartnerMr. Kieran Mudryy, Partner, General CounselMr. Owen Smith, Investment Director
4BIO Ventures II
€ 45,000,000
Early stage fund
4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early-stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals including Nature, The Lancet, Cell, and the New England Journal of Medicine. 4BIO has both an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space. For more information, please visit www.4biocapital.com